Westwind Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-29,713
| Closed | -$16.7M | – | 88 |
|
|
2026
Q1 | $16.7M | Sell |
29,713
-977
| -3% | -$627K | 4.01% | 12 |
|
|
2025
Q4 | $20.8M | Sell |
30,690
-451
| -1% | -$307K | 4.24% | 8 |
|
|
2025
Q3 | $19.9M | Sell |
31,141
-14,604
| -32% | -$8.86M | 4.16% | 9 |
|
|
2025
Q2 | $24.5M | Sell |
45,745
-91
| -0.2% | -$43.5K | 5.02% | 9 |
|
|
2025
Q1 | $19.2M | Buy |
45,836
+1,174
| +3% | +$510K | 4.79% | 10 |
|
|
2024
Q4 | $18.5M | Buy |
44,662
+1,211
| +3% | +$531K | 4.03% | 11 |
|
|
2024
Q3 | $22M | Sell |
43,451
-4,915
| -10% | -$2.39M | 5.33% | 7 |
|
|
2024
Q2 | $20.7M | Buy |
48,366
+6,097
| +14% | +$3.06M | 5.15% | 9 |
|
|
2024
Q1 | $22.8M | Buy |
42,269
+63
| +0.1% | +$34.4K | 5.78% | 5 |
|
|
2023
Q4 | $23.4M | Buy |
42,206
+25
| +0.1% | +$11.7K | 6.39% | 3 |
|
|
2023
Q3 | $18.4M | Buy |
42,181
+96
| +0.2% | +$47.9K | 5.68% | 8 |
|
|
2023
Q2 | $21.1M | Buy |
42,085
+177
| +0.4% | +$84.8K | 5.92% | 4 |
|
|
2023
Q1 | $21M | Sell |
41,908
-652
| -2% | -$312K | 6.7% | 5 |
|
|
2022
Q4 | $17.4M | Buy |
42,560
+278
| +0.7% | +$108K | 5.91% | 6 |
|
|
2022
Q3 | $13.8M | Buy |
42,282
+385
| +0.9% | +$141K | 4.83% | 7 |
|
|
2022
Q2 | $14.7M | Buy |
41,897
+596
| +1% | +$243K | 4.81% | 10 |
|
|
2022
Q1 | $22.6M | Buy |
41,301
+12,518
| +43% | +$6.58M | 6.08% | 6 |
|
|
2021
Q4 | $19M | Buy |
28,783
+1,585
| +6% | +$995K | 4.69% | 9 |
|
|
2021
Q3 | $16.9M | Sell |
27,198
-10,560
| -28% | -$7.1M | 4.5% | 12 |
|
|
2021
Q2 | $23.8M | Buy |
37,758
+208
| +0.6% | +$115K | 5.73% | 8 |
|
|
2021
Q1 | $18.4M | Sell |
37,550
-4,981
| -12% | -$2.5M | 5.32% | 10 |
|
|
2020
Q4 | $21.3M | Sell |
42,531
-206
| -0.5% | -$92.2K | 6.2% | 7 |
|
|
2020
Q3 | $16.8M | Buy |
42,737
+776
| +2% | +$287K | 5.65% | 9 |
|
|
2020
Q2 | $13.9M | Buy |
41,961
+482
| +1% | +$140K | 5.25% | 10 |
|
|
2020
Q1 | $10M | Buy |
41,479
+2,349
| +6% | +$613K | 5.19% | 11 |
|
|
2019
Q4 | $10.2M | Buy |
39,130
+901
| +2% | +$237K | 4.96% | 10 |
|
|
2019
Q3 | $10.4M | Buy |
38,229
+1,264
| +3% | +$352K | 5.49% | 8 |
|
|
2019
Q2 | $10.2M | Buy |
36,965
+796
| +2% | +$196K | 5.78% | 8 |
|
|
2019
Q1 | $8.09M | Buy |
36,169
+2,263
| +7% | +$467K | 4.77% | 9 |
|
|
2018
Q4 | $6.31M | Buy |
33,906
+1,920
| +6% | +$394K | 4.53% | 10 |
|
|
2018
Q3 | $7.99M | Sell |
31,986
-21,119
| -40% | -$5.13M | 5.04% | 9 |
|
|
2018
Q2 | $11.6M | Sell |
53,105
-1,594
| -3% | -$328K | 8.78% | 3 |
|
|
2018
Q1 | $10.5M | Sell |
54,699
-226
| -0.4% | -$41.7K | 8.39% | 3 |
|
|
2017
Q4 | $8.59M | Buy |
+54,925
| New | +$8.65M | 8.1% | 5 |
|
Other funds holding IDXX
Westwind Capital's IDXX Position: Q2 2026 in Review
Westwind Capital sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 29,713 shares — an estimated $16.7M sold.
Westwind Capital first reported a position in IDXX in Q4 2017 and held it in 34 quarters. The position peaked at $24.5M in Q2 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Westwind Capital reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
- Westwind Capital sold 29,713 Idexx Laboratories shares in Q2 2026, an estimated $16.7M.
- Westwind Capital first reported a position in Idexx Laboratories in Q4 2017 and held it in 34 quarters.
- Westwind Capital's Idexx Laboratories position peaked at $24.5M in Q2 2025.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Westwind Capital's 13F filing for Q2 2026, filed 15 Jul 2026.